Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all interested, just my two cents.

All true....but factor the possibility of a defined business strategy of dividends into the share price. If PTSC should win there should be a foreseeable stream of licenses for a few years to come.

50 cents a share for a stock issuing quarterly dividends seems a bit low.

teremoto

Share
New Message
Please login to post a reply